Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging

被引:101
作者
Rogers, WJ
Basu, P
机构
[1] Univ Virginia Hlth Syst, Dept Radiol, Charlottesville, VA 22908 USA
[2] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22908 USA
[3] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15219 USA
关键词
magnetic resonance imaging; atherosclerosis; inflammation;
D O I
10.1016/j.atherosclerosis.2004.08.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The presence of activated macrophages (MO) is an early and consistent marker of the inflammatory nature of atherosclerotic disease. Dextran-coated superparamagnetic iron oxide particles (SPIO) are avidly endocytosed. These particles have a strong effect on magnetic resonance signal and have been proposed as a non-invasive probe for the presence of early non-occlusive atherosclerotic disease. We describe the extent to which endogenous and exogenous factors regulate MO uptake of SPIO particles. Methods and results: Cultured murine MO-like cells (J744A.1) incubated with SPIO (0. 11.2. 112.0 and 1120 121 mug Fe/ml) demostrated significantly reduced SPIO uptake when pretreated with lovastatin to 61% (P < 0.001) and 43% (P = 0.02) of control at 1.0 muM and 17.5 muM lovastatin respectively. Interferon-gamma (IFN-gamma, 1000 U/ml) increased SPIO uptake to 163%. of control. P < 0.05. Interleukin-4 (IL-4. 40ng/ml) also increased uptake (178% of control, P < 0.04). In cells incubated with SPIO in the absence of serum proteins. SPIO uptake fell to 57% of control (P < 0.001). Conclusions: Uptake of SPIO by activated MO is regulated by endogenous cytokines and serum components as well I and exogenous lovastatin. Thus, MRI signal changes after SPIO administration may reflect MO phagocytic.,tic capacity, as well as Mtheta presence. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 28 条
[1]   The IFN gamma receptor: A paradigm for cytokine receptor signaling [J].
Bach, EA ;
Aguet, M ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :563-&
[2]   HMG-COA REDUCTASE INHIBITORS REDUCE ACETYL LDL ENDOCYTOSIS IN MOUSE PERITONEAL-MACROPHAGES [J].
BERNINI, F ;
SCURATI, N ;
BONFADINI, G ;
FUMAGALLI, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (09) :1352-1358
[3]   EFFECT OF PHAGOCYTOSIS ON RECEPTOR DISTRIBUTION AND ENDOCYTIC ACTIVITY IN MACROPHAGES [J].
BUYS, SS ;
KAPLAN, J .
JOURNAL OF CELLULAR PHYSIOLOGY, 1987, 131 (03) :442-449
[4]  
Davies PF, 2002, BIORHEOLOGY, V39, P299
[5]   Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen [J].
Divi, RL ;
Dragan, YP ;
Pitot, HC ;
Poirier, MC .
CARCINOGENESIS, 2001, 22 (10) :1693-1699
[6]   MAGNETIC STARCH MICROSPHERES - INTERACTIONS OF A MICROSPHERE MR CONTRAST-MEDIUM WITH MACROPHAGES INVITRO [J].
FAHLVIK, AK ;
ARTURSSON, P ;
EDMAN, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 65 (03) :249-259
[7]  
*FER, 1998, FER PACK INS
[8]   Alternative activation of macrophages [J].
Gordon, S .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (01) :23-35
[9]   Lovastatin decreases the receptor-mediated degradation of acetylated and oxidized LDLs in human blood monocytes during the early stage of differentiation into macrophages [J].
Hrboticky, N ;
Draude, G ;
Hapfelmeier, G ;
Lorenz, R ;
Weber, PC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (05) :1267-1275
[10]   Monocyte chemoattractant protein-1 and coronary artery disease [J].
Ikeda, U ;
Matsui, K ;
Murakami, Y ;
Shimada, K .
CLINICAL CARDIOLOGY, 2002, 25 (04) :143-147